Acute hepatitis secondary to parenteral amiodarone does not preclude subsequent oral therapy

World Journal of Hepatology

Volumn 4, Issue 6, 2012, Pages 196-198

  Lahbabi, Mounia ^a   Aqodad, Nouredine ^a   Ibrahimi, Adil ^a   Lahlou, Mryem ^a   Aqodad, Hafid ^a  

^a HASSAN II UNIVERSITY HOSPITAL   (Morocco)

Author keywords

Amiodarone; Hepatitis; Polyoxenethylated sorbitan ester; Toxic hepatitis

Indexed keywords

EID: 84886826331     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v4.i6.196     Document Type: Article

References (12)

1. Kang HM, Kang YS, Kim SH, Seong JK, Kang DY, Lee HY, Lee BS. Amiodarone-induced hepatitis and polyneuropathy. Korean J Intern Med 2007; 22: 225-229
2. Puli SR, Fraley MA, Puli V, Kuperman AB, Alpert MA. Hepatic cirrhosis caused by low-dose oral amiodarone therapy. Am J Med Sci 2005; 330: 257-261
3. McGovern B, Garan H, Kelly E, Ruskin JN. Adverse reactions during treatment with amiodarone hydrochloride. Br Med J (Clin Res Ed) 1983; 287: 175-180
4. James PR, Hardman SM. Acute hepatitis complicating parenteral amiodarone does not preclude subsequent oral therapy. Heart 1997; 77: 583-584
5. Paniagua Clusells J, Arcusa Gavalda R, Goma Masip F, Pons Masanes S, Soler Masana JM. [Acute hepatitis caused by intravenous amiodarone]. Rev Esp Cardiol 1996; 49: 384-385
6. López-Gómez D, Nicolás J, Frigola JM, Manito N, Esplugas E. [The use of oral amiodarone as a chronic treatment in a patient with prior fulminant hepatitis due to intravenous amiodarone]. Rev Esp Cardiol 1999; 52: 201-203
7. Cataldi A, Gonella D, Robutti N, Siri M, Buonocore S, Odetti P. Hepatotoxicity after intravenous amiodarone. Aging Clin Exp Res 2008; 20: 593-596
8. Rätz Bravo AE, Drewe J, Schlienger RG, Krähenbühl S, Pargger H, Ummenhofer W. Hepatotoxicity during rapid intravenous loading with amiodarone: Description of three cases and review of the literature. Crit Care Med 2005; 33: 128-134; discussion 245-246
9. Chan AL, Hsieh HJ, Hsieh YA, Lin SJ. Fatal amiodarone-induced hepatotoxicity: a case report and literature review. Int J Clin Pharmacol Ther 2008; 46: 96-101
10. Stevenson RN, Nayani TH, Davies JR. Acute hepatic dysfunction following parenteral amiodarone administration. Postgrad Med J 1989; 65: 707-708
11. Giannattasio F, Salvio A, Varriale M, Picciotto FP, Di Costanzo GG, Visconti M. Three cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingredient is not the only agent responsible for hepatotoxicity. Ann Ital Med Int 2002; 17: 180-184
12. Rhodes A, Eastwood JB, Smith SA. Early acute hepatitis with parenteral amiodarone: a toxic effect of the vehicle?. Gut 1993; 34: 565-566